When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - FDA clears Cytodyn's mid-stage leronlimab trial for mild-to-moderately ill Covid-19 patients
CytoDyn Inc
CytoDyn (OTCQB:CYDY) announces that the FDA has provided clearance for initiation of a Phase 2 trial with leronlimab to treat COVID-19 patients with mild to moderate indications.
More news on: CytoDyn Inc., Healthcare stocks news,